• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Allergies? Exhausted regulatory T cells may play a role

Bioengineer by Bioengineer
August 23, 2017
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Seth Dixon / St. Jude Children's Research Hospital

Researchers have evidence that the specialized T cells responsible for maintaining a balanced immune response are vulnerable to exhaustion that disrupts normal functioning and may even contribute to allergic reactions. St. Jude Children's Research Hospital scientists led the study, which appeared today as an advance online publication in the scientific journal Nature.

The report is believed to be the first to suggest that regulatory T cells are subject to the functional exhaustion that also plagues conventional T cells that fight infectious agents and tumor cells. Regulatory T cells are a small population of lymphocytes that keep the immune system in check and help to prevent asthma, allergies and autoimmune disorders like multiple sclerosis and lupus.

Investigators focused on the tumor suppressor liver kinase B1 (LKB1), a protein that controls cell growth and metabolism. Working in mice, researchers showed how, at the molecular level, loss of LKB1 in regulatory T cells disrupted cell metabolism and function. The mice developed fatal inflammatory disease and their regulatory T cells showed functional, molecular and other changes characteristic of functional exhaustion. "We know regulatory T cells can be resting or activated," said corresponding author Hongbo Chi, Ph.D., a member of St. Jude Department of Immunology. "Our observations suggest regulatory T cells can also become functionally exhausted when they lose LKB1 signaling."

The results point to functional exhaustion of regulatory T cells as a possible culprit in the immune response associated with allergic reaction, known as the Th2 response. "The research suggests a possible new therapeutic approach to autoimmune disorders that would be designed to boost the function of regulatory T cells by modulating cell metabolism," Chi said.

The research also highlighted the role of metabolism in proper immune function. Deletion of LKB1 in regulatory T cells disrupted metabolic pathways that support the health and function of the mitochondria. Mitochondria produce energy to power cells. "LKB1 connects immunological signals and cell metabolic programs, especially those related to mitochondrion function," said first author Kai Yang, Ph.D., a staff scientist in Chi's laboratory.

Investigators linked the ability of regulatory T cells to dampen the Th2 response in part to the ability of LKB1 to restrain expression of the cell surface receptor PD-1 and possibly other receptors. In conventional T cells, PD-1 helps inhibit their activity and the immune response to prevent undesired immune responses that lead to autoimmune diseases.

But loss of LKB1 led to increased production of PD-1 by regulatory T cells. That increase inhibited the ability of regulatory T cells to suppress the Th2 immune response in mice. Blocking PD-1 activity largely restored the ability of regulatory T cells that lacked LKB1 to suppress the Th2 immune response.

"Our data suggest that PD-1 also inhibits functions of regulatory T cells, thus inhibiting the inhibitor since inhibition is the role of regulatory T cells," Chi said. Researchers also found evidence that LKB1 helped to control the Th2 response through additional processes. For instance, LKB1 also helped to repress cell surface markers on immune cells called dendritic cells that fueled the allergic reaction. Loss of LKB1 by regulatory T cells was also associated with increased levels of signaling molecules or cytokines associated with the Th2 immune response, Kai said.

Researchers filled in other details about the selective role of LKB1 in regulatory T cells, including that the molecule unexpectedly works through the Wnt signaling pathway to adjust regulatory T cell function. LKB1 is known to work through different pathways, primarily the mTORC1 and AMPK signaling pathways, in conventional T cells and other settings.

###

The other authors are Daniel Bastardo Blanco, Geoffrey Neale, Peter Vogel, Sharad Shrestha, Sherri Rankin, Lingyun Long and Anil KC, all of St. Jude; Julian Avila and Clary Clish, both of the Broad Institute of MIT and Harvard University, Cambridge, Massachusetts; and Chuan Wu, of Brigham and Women's Hospital, Harvard Medical School, Boston.

The research was funded in part by grants (AI105887, AI101407, CA176624, NS064599) from the National Institutes of Health; the American Asthma Foundation; and ALSAC, the fundraising and awareness organization of St. Jude.

Media Contact

Corey Carmichael
[email protected]
901-595-0222
@StJudeResearch

http://www.stjude.org

Related Journal Article

http://dx.doi.org/10.1038/nature23665

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Researchers Chart Navigation Strategies of Wild Cats and Dogs

September 29, 2025
Breakthrough Achievement: In Vitro Simultaneous Synthesis of All 21 tRNA Types

Breakthrough Achievement: In Vitro Simultaneous Synthesis of All 21 tRNA Types

September 29, 2025

Pathogenic Bacteria and Quality in Cold-Stored Korean Veggies

September 29, 2025

Innovative Tool Pinpoints Proteins Regulating Gene Activity

September 29, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    87 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    73 shares
    Share 29 Tweet 18
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    58 shares
    Share 23 Tweet 15
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Shorter Radiation Enhances Patient Comfort Without Boosting Disease Control in Intermediate-Risk Prostate Cancer

AI-Driven Body Composition Analysis Forecasts Cardiometabolic Risk

First Randomized Trial Shows Proton and Photon Radiation Therapies Equally Preserve Quality of Life in Breast Cancer Patients

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.